Most not too long ago, it has been discovered that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to the wide array of endogenous opioids. Not like most opioid receptors, this receptor https://thomasq825jjg7.blogscribble.com/profile